In this issue of Child and Adolescent Psychiatric Clinics, guest editors Drs. Jeffrey Strawn and Justine Larson bring their considerable expertise to the topic of Updates in Anxiety Treatment. Top experts in the field cover key topics such as risk factors for anxiety disorders; neurobiology of pediatric anxiety disorders; treatment of anxiety disorders in the primary care pediatric setting; dysregulation in pediatric anxiety disorders; and more. - Contains 11 relevant, practice-oriented topics including the impact of COVID-19 on anxiety disorders in youth; advances in CBT for anxiety disorders; psychodynamic formulation and treatment of anxiety disorders in youth; social media and pediatric anxiety disorders; and more. - Provides in-depth clinical reviews on updates in anxiety treatment, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Pediatric Anxiety Disorders provides a critical, updated and comprehensive overview of anxiety disorders in children and adolescents based on the current state of empirical research. The book provides specific clinical recommendations which integrate new knowledge from neuroscience and innovative delivery formats for interventions. This is the first reference to examine anxiety diagnoses in accordance with the latest edition of the DSM-5, including childhood onset disorders, such as Separation Anxiety Disorder, Selective Mutism, Specific Phobia, Social Anxiety Disorder, Panic Disorder, Agoraphobia and Generalized Anxiety Disorder. The book assists clinicians in critically appraising the certainty of the evidence-base and the strength of clinical recommendations. - Uses the latest edition of the Diagnostic and Statistical Manual of Mental Disorders, the DSM-5 - Includes the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach in assessing guideline development - Focuses on advances in etiology, assessment and treatment - Presents new advances in our understanding of the brain behind fear and anxiety - Uses a stepped care approach to treatment

This issue provides a unique and valuable perspective on forensic matters in child and adolescent psychiatry, with an approach that adds new thinking to the discussion, rather than rehashing known facts. The issue is divided into several sections: juvenile offenders, family law/custody and visitation, child maltreatment, personal injury law suits, forensic issues in clinical child and adolescent psychiatry, and training in child and adolescent psychiatry. A wide range of topics are explored within each section. All articles are geared toward child psychiatrists in clinical practice, providing practical information in this very important area of study.

Child and Adolescent Anxiety Psychodynamic Psychotherapy, CAPP, is a new, manualized, tested, 24-session psychotherapeutic approach to working psychodynamically with youth with anxiety disorders. This book describes how clinicians intervene by collaboratively identifying the meanings of anxiety symptoms and maladaptive behaviors and to communicate the emotional meaning of these symptoms to the child. The treatment is conducted from a developmental perspective and the book contains clinical examples of how to approach youth of varying ages. The authors demonstrate that CAPP can help youth: · Reduce anxiety symptoms by developing an understanding of the emotional meaning of symptoms · Enhance children's skill of reflection and self-observation of one's own and others' motivations (improvement in symptom-specific reflective functioning) · Diminish use of avoidance, dependence and rigidity by showing that underlying emotions (e.g. guilt, shame, anger), as well as conflicted wishes and desires can be tolerated and understood · Understand fantasies and personal emotional significance surrounding the anxiety symptoms to reduce symptoms' magical qualities and impact on the child The manual provides a description of psychodynamic treatment principles and technique and offers a guide to opening, middle, and termination phases of this psychotherapy. It contains chapters on the historical background of psychodynamic child psychotherapy, on developmental aspects of child psychotherapy, and on the nature of parent involvement in the treatment. It will be useful for clinicians from diverse therapy backgrounds and it will appeal to the student reader, as well as to the experienced clinician.

The book collates the latest innovations in cognitive behavioral therapy for child and adolescent anxiety disorders, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD).

Psychopharmacology is a dominant treatment in child and adolescent psychiatry with proven benefits to young patients. The authors present topics related to PSYCHOPHARMACOLOGY ISSUES: Ethical issues, Treatment planning, Side effects, Neural correlates, and Pharmacogenomics. They address DRUGS FOR SPECIFIC DISEASES: Anxiety, Depression, Eating disorders, Sleep disorders, Psychosis and Schizophrenia, High-risk for bilpolar and schizophrenia, Bipolar, ADHD, and Autism. Each topic presents an Overview of the Disease or Issue, Empirical evidence for ethical issues, Treatment summaries that include dose ranges, side effects, contraindications, and how the drugs are used specifically for a disorder. Treatment in the presence of co-morbid conditions, Long-term evidence, and Conclusions and Future directions complete the presentations. Clinical vignettes are provided that exemplify the main points of the topic.

Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders.